Cerebral perfusion and haemodynamics measured by SPET in symptom-free patients with transient ischaemic attack: Clinical implications

European Journal of Nuclear Medicine

Volumn 28, Issue 12, 2001, Pages 1828-1835

  Martí Fàbregas, Joan ^a   Catafau, Ana M ^a   Marí, Carina ^a   Mendoza, Gabriel ^a   Sanahuja, Jordi ^a   Lleó, Alberto ^a   Martí Vilalta, Josep Lluis ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Acetazolamide; Cerebrovascular reserve; Regional cerebral blood flow; Single photon emission tomography; Transient ischaemic attack

Indexed keywords

ACETAZOLAMIDE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HEMODYNAMIC MONITORING; HUMAN; MALE; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSIENT ISCHEMIC ATTACK;

ACETAZOLAMIDE; AGED; CEREBROVASCULAR CIRCULATION; DIURETICS; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RISK FACTORS; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035207984     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-001-0656-6     Document Type: Article

References (43)

1. Transient ischemic neurologic deficits
2. Interobserver agreement for the diagnosis of transient ischemic attacks
3. Diagnosis of transient ischemic attacks: Improvement of interobserver agreement by a check-list in ordinary language
4. Guidelines for the management of transient ischemic attacks
5. Brain SPECT and thrombolysis in acute ischemic stroke: Time for a clinical trial
6. Single photon emission computed tomography in cerebrovascular disease
7. Value of single-photon emission-computed tomography in acute stroke therapeutic trials
8. Clinical usefulness of technetium-99m HMPAO SPECT imaging to map the ischemic lesion in acute stroke: A reevaluation
9. Report of the Therapeutics and Technology Assessment subcommittee of the American Academy of Neurology
10. Evaluation of the cerebral vasodilatory capacity by the acetazolamide test before EC-IC bypass surgery in patients with occlusion of the internal carotid artery
11. Carotid artery disease: Evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT
12. 99mTc HMPAO SPECT in patients with cerebrovascular disease
13. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke
14. Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: Relation to clinical outcome
15. Comparative correlations of HMPAO SPECT indices, neurological score and stroke subtypes with clinical outcome in acute carotid infarcts
16. Brain perfusion defect size in SPECT predicts outcome in cerebral infarction
17. rCBF-SPECT in brain infarction: When does it predict outcome?
18. SPECT study of cerebral blood flow reactivity after acetazolamide in patients with transient ischemic attacks
19. Factors causing prolonged hypoperfusion after transient ischemic attack
20. Prolonged hypoperfusion and early stroke after transient ischemic attack
21. Persisting perfusion defect in transient ischemic attacks. A new clinically useful subgroup?
22. A classification and outline of cerebrovascular diseases. Part II
23. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
24. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke. A report of Stroke Council, American Heart Association
25. One-day protocol for cerebral perfusion reserve with acetazolamide
26. Is image subtraction necessary in the clinical interpretation of single-day split-dose stress cerebral perfusion single-photon emission tomography using technetium-99m compounds?
27. 99mTc-HMPAO SPECT study
28. Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexone challenge during detoxification
29. Prolonged disturbances of regional cerebral blood flow in transient ischemic attacks
30. Positron emission tomography imaging and the therapeutic window
31. Diffusion MRI in patients with transient ischemic attacks
32. Ischemic tolerance in the brain
33. Positron emission tomography and its application to the study of cerebrovascular disease in man
34. Ischemic stroke and incomplete infarction
35. Reversal of acute apparent diffusion coefficient abnormalities and delayed neuronal death following transient focal cerebral ischemia in rats
36. Temporal evolution of ischemic injury evaluated with diffusion-, perfusion-, and T2-weighted MRI
37. Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats: Correlation with histopathology
38. Cerebral metabolism after transient ischemic attack. A 1H MR spectroscopy study
39. Use of a decibel threshold in detecting Doppler embolic signals
40. Clinical correlations of Doppler microembolic signals in patients with prosthetic cardiac valves. Analysis of 580 cases
41. Silent stroke in patients with transient ischemic attacks or minor ischemic stroke
42. Cerebral vasocapacitance and TIAs
43. Hemodynamic cerebral ischemia. An appeal for systematic data gathering prior to a new EC/IC trial